Navigation Links
VIVUS to Present at Four Upcoming Healthcare Conferences

MOUNTAIN VIEW, Calif., Sept. 1 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Timothy Morris, Chief Financial Officer, will present an overview of the company at four healthcare investment conferences during the month of September.

The conference presentation schedule is as follows:

        Rodman & Renshaw Annual Global Investment Conference
        September 10, 2009 at 10:50 a.m. ET
        The New York Palace Hotel, New York, NY

        Thomas Weisel Partners Healthcare Conference
        September 11, 2009 at 11:30 a.m. ET
        The Four Seasons Hotel, Boston, MA

        BioCentury's NewsMakers in the Biotech Industry Conference
        September 16, 2009 at 3:30 p.m. ET
        Millennium Broadway Hotel & Conference Center, New York, NY

        UBS Global Life Sciences Conference
        September 21, 2009 at 3:30 p.m. ET
        Grand Hyatt, New York, NY

A live audio webcast and 30-day archive of the presentations will be available on VIVUS' website at


VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead product in clinical development, Qnexa(TM), is expected to complete phase 3 clinical trials for the treatment of obesity in 2009. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a potentially best-in-class PDE5 inhibitor, and in phase 2 development of Luramist(TM) for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE(R) (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information about the company, please visit

    Timothy E. Morris
    Chief Financial Officer
    VIVUS, Inc.

    Brian Korb
    Investor Relations
    The Trout Group,

    Sheryl Seapy
    Media Relations
    Pure Communications, Inc.

Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. VIVUS to Present at the Canaccord Adams 29th Annual Global Growth Conference
2. VIVUS to Present at the Needham and Company Life Sciences Conference
3. Data on VIVUS Qnexa To Be Presented During Two Podium Presentations at ADA Annual Meeting
4. VIVUS Reports First Quarter 2009 Financial Results and Highlights
5. Peregrine Pharmaceuticals to Present at the Rodman & Renshaw 11th Annual Healthcare Conference
6. AEterna Zentaris to Present at Upcoming Rodman Renshaw Annual Global Investment Conference
7. Masimo to Present at the Thomas Weisel Partners Healthcare Conference 2009
8. Cardio3 BioSciences Presents Update on C-Cure(R) Second Generation Stem Cell Therapy for Heart Failure at European Society of Cardiology Congress
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Tianyin Pharmaceutical, Co. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 11 at 10:50 am ET
11. Dendreon Announces Analyst Day Webcast Presentation to be Held on September 24, 2009
Post Your Comments:
(Date:11/24/2015)... , ... November 24, 2015 , ... This fall, global ... competitive events in five states to develop and pitch their BIG ideas to improve ... each state are competing for votes to win the title of SAP's Teen Innovator, ...
(Date:11/24/2015)... 24, 2015 SHPG ) announced today that ... Piper Jaffray 27 th Annual Healthcare Conference in ... at 8:30 a.m. EST (1:30 p.m. GMT). --> SHPG ... will participate in the Piper Jaffray 27 th Annual Healthcare ... Tuesday, December 1, 2015, at 8:30 a.m. EST (1:30 p.m. GMT). ...
(Date:11/24/2015)... 24, 2015  Tikcro Technologies Ltd. (OTCQB: TIKRF) today announced that its ... at 11:00 a.m. Israel time, at the law ... Allon Street, 36 th Floor, Tel Aviv, Israel ... and Izhak Tamir to the Board of Directors; ... directors; , approval of an amendment to certain terms of options ...
(Date:11/24/2015)... Nov. 24, 2015  Twist Bioscience, a company ... Leproust, Ph.D., Twist Bioscience chief executive officer, will ... on December 1, 2015 at 3:10 p.m. Eastern ... City. --> --> ... Twist Bioscience is on Twitter. Sign up to ...
Breaking Biology Technology:
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
(Date:11/12/2015)... --  Growing need for low-cost, easy to use, ... the way for use of biochemical sensors for ... clinical, agricultural, environmental, food and defense applications. Presently, ... applications, however, their adoption is increasing in agricultural, ... on improving product quality and growing need to ...
(Date:11/9/2015)... SAN JOSE, Calif. , Nov. 9, 2015 /PRNewswire/ ... of human interface solutions, today announced broader entry into ... of vehicle-specific solutions that match the pace of consumer ... drivers, and biometric sensors are ideal for the automotive ... the vehicle. Europe , ...
Breaking Biology News(10 mins):